{
    "clinical_study": {
        "@rank": "99334", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subject inhales no drug (100% oxygen)"
            }, 
            {
                "arm_group_label": "0.3% sevoflurane", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "0.6% sevoflurane", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "15% Nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "30% Nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to conduct experiments to examine subjective and reinforcing\n      effects of nitrous oxide.  Mood altering and psychomotor effects will be tested on non-drug\n      abusers and preference procedures will be used to assess reinforcing effects.  Comparisons\n      between nitrous oxide, opiates, and benzodiazepine antagonists will be made.   To examine\n      sevoflurane versus isoflurane inhalation at subanesthetic concentrations on mood, pain, and\n      psychomotor performance."
        }, 
        "brief_title": "Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11", 
        "completion_date": {
            "#text": "November 1997", 
            "@type": "Actual"
        }, 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "39 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000259", 
            "org_study_id": "NIDA-08391-11", 
            "secondary_id": [
                "R01DA008391", 
                "R01-08391-11"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "15% Nitrous oxide", 
                "intervention_name": "15 % Nitrous oxide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "0.3% sevoflurane", 
                "intervention_name": "0.3 % Sevoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "30% Nitrous oxide", 
                "intervention_name": "30% Nitrous oxide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "0.6% sevoflurane", 
                "intervention_name": "0.6% Sevoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nitrous Oxide", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "University of Chicago, Anesthesia & Critical Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations", 
        "overall_official": {
            "affiliation": "University of Chicago", 
            "last_name": "James Zacny, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 1997", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Subjects underwent a 3 min cold immersion test at 30 min of inhalation and then provided response to pain intensity questionnaire", 
                "measure": "Pain intensity", 
                "safety_issue": "No", 
                "time_frame": "30 min of inhalation"
            }, 
            {
                "description": "Subjects underwent psychomotor testing at baseline, during inhalation, and during recovery post inhalation", 
                "measure": "Psychomotor performance", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 5 min of inhalation; 5, 30, 60 minutes recovery"
            }, 
            {
                "description": "Subject underwent memory, sedation, visual analog, and drug effects testing", 
                "measure": "Cognitive performance", 
                "safety_issue": "No", 
                "time_frame": "Baseline, every 5 min during inhalation, 5, 30, & 60 min during recovery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000259"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1996", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }, 
    "geocoordinates": {
        "University of Chicago, Anesthesia & Critical Care": "41.878 -87.63"
    }
}